| 000 | 01806 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250513203316.0 | ||
| 264 | 0 | _c20000316 | |
| 008 | 200003s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm9904102 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKolasa, T | |
| 245 | 0 | 0 |
_aHeteroarylmethoxyphenylalkoxyiminoalkylcarboxylic acids as leukotriene biosynthesis inhibitors. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cFeb 2000 |
||
| 300 |
_a690-705 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAcrylic Resins |
| 650 | 0 | 4 |
_aAnaphylaxis _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Allergic Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xchemical synthesis |
| 650 | 0 | 4 |
_aAscitic Fluid _xmetabolism |
| 650 | 0 | 4 |
_aGranuloma _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aLeukotriene B4 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 |
_aPleuropneumonia _xdrug therapy |
| 650 | 0 | 4 |
_aPneumonia _xdrug therapy |
| 650 | 0 | 4 |
_aQuinolines _xchemical synthesis |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aGunn, D E | |
| 700 | 1 | _aBhatia, P | |
| 700 | 1 | _aWoods, K W | |
| 700 | 1 | _aGane, T | |
| 700 | 1 | _aStewart, A O | |
| 700 | 1 | _aBouska, J B | |
| 700 | 1 | _aHarris, R R | |
| 700 | 1 | _aHulkower, K I | |
| 700 | 1 | _aMalo, P E | |
| 700 | 1 | _aBell, R L | |
| 700 | 1 | _aCarter, G W | |
| 700 | 1 | _aBrooks, C D | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 43 _gno. 4 _gp. 690-705 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm9904102 _zAvailable from publisher's website |
| 999 |
_c10645902 _d10645902 |
||